{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "Dealbook", "document_type": "blogpost", "multimedia": [], "abstract": "Nestl\u00e9 Health Science is investing $65 million in Seres Health, a start-up focused on restoring the \u201cmicrobiome,\u201d the host of microorganisms that provide vital functions for humans.", "type_of_material": "Blog", "word_count": "512", "lead_paragraph": null, "pub_date": "2015-01-06T07:00:17Z", "_id": "54abced038f0d83eda14cdc5", "byline": {"original": "By MICHAEL J. DE LA MERCED", "person": [{"middlename": "J.", "firstname": "Michael", "lastname": "DE LA MERCED", "rank": 1, "role": "reported", "organization": ""}]}, "source": "The New York Times", "snippet": "Nestl\u00e9 Health Science is investing $65 million in Seres Health, a start-up focused on restoring the \u201cmicrobiome,\u201d the host of microorganisms that provide vital functions for humans.", "web_url": "http://dealbook.nytimes.com/2015/01/06/nestle-health-sciences-to-invest-65-million-in-a-boston-biotech-start-up/", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "value": "Nestle SA", "name": "organizations"}, {"rank": "1", "value": "Biotechnology and Bioengineering", "name": "subject"}, {"rank": "2", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "3", "value": "Microbiology", "name": "subject"}, {"rank": "4", "value": "Start-ups", "name": "subject"}], "headline": {"main": "Nestl\u00e9 Health Science to Invest $65 Million in a Biotech Start-Up", "kicker": "DealBook"}}